Universitätsklinikum Bonn

Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression (vol 25, pg 1551, 2014) (2017) Nitz U, Gluz O, Huober J, Kreipe HH, Kates RE, Hartmann A, Erber R, et al. Journal article Fumaric Acid Esters: Patient Characteristics and Duration of Therapy from the PsoBest German Psoriasis Registry (2017) Augustin M, Reich K, Spehr C, Rustenbach SJ, Mrowietz U, Radtke MA, Wilsman-Theis D, et al. Conference contribution SOP-palliative sedation (2017) Oechsle K, Radbruch L, Wolf C, Ostgathe C Journal article THERAPEUTIC IMPACT OF FILARIAL ANTIGEN OF LITOMOSOIDES SIGMODONTIS ON ADVANCED ATHEROSCLEROSIS IN APOE-KNOCKOUT MICE, BASED ON T CELL DIFFERENTIATION (2017) Kühn C, Tauchi M, Hoerauf A, Stumpf C, Achenbach S, Huebner M, Dietel B Conference contribution Intermediate Follow-up of Pediatric Patients With Hemolytic Uremic Syndrome During the 2011 Outbreak Caused by E. coli O104:H4 (2017) Loos S, Aulbert W, Hoppe B, Ahlenstiel-Grunow T, Kranz B, Wahl C, Staude H, et al. Journal article Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany (2017) Schmitt J, Abraham S, Trautmann F, Stephan V, Foelster-Holst R, Homey B, Bieber T, et al. Journal article Mapping and predicting mortality from systemic sclerosis (2017) Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, et al. Journal article Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Frontal Lobe Epilepsy: A New Clinico-Pathological Entity (2017) Schurr J, Coras R, Roessler K, Pieper T, Kudernatsch M, Holthausen H, Winkler P, et al. Journal article Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO) (2017) Mellinghoff SC, Panse J, Alakel N, Behre G, Buchheidt D, Christopeit M, Hasenkamp J, et al. Journal article Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants (2017) Hehlmann R, Lauseker M, Saussele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, et al. Journal article